{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:23:55Z","timestamp":1761899035859,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cancergen.2018.04.119","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T05:04:46Z","timestamp":1525928686000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Challenges in next generation sequencing analysis of somatic mutations in transplant patients"],"prefix":"10.1016","volume":"226-227","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajyalakshmi","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5081-2427","authenticated-orcid":false,"given":"Keyur P","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Routbort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinchita","family":"Roy-Chowdhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Manekia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh R","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Yemelyanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2018.04.119_bib0001","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jmoldx.2016.10.007","article-title":"Analytical validation of the next-generation sequencing assay for a nationwide signal-finding clinical trial: molecular analysis for therapy choice clinical trial","volume":"19","author":"Lih","year":"2017","journal-title":"J Mol Diagn (JMD)"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0003","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0004","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.drudis.2015.08.005","article-title":"Precision medicine at Memorial Sloan Kettering cancer center: clinical next-generation sequencing enabling next-generation targeted therapy trials","volume":"20","author":"Hyman","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0005","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood-2015-08-664649","article-title":"Integrated genomic DNA\/RNA profiling of hematologic malignancies in the clinical setting","volume":"127","author":"He","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0006","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1158\/1078-0432.CCR-14-2683","article-title":"Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches","volume":"21","author":"Drilon","year":"2015","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0007","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jmoldx.2013.05.003","article-title":"Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes","volume":"15","author":"Singh","year":"2013","journal-title":"J Mol Diagn (JMD)"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn (JMD)"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0009","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jmoldx.2016.09.011","article-title":"A targeted high-throughput next-generation sequencing panel for clinical screening of mutations, gene amplifications, and fusions in solid tumors","volume":"19","author":"Luthra","year":"2017","journal-title":"J Mol Diagn (JMD)"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3390\/cancers7040874","article-title":"Next-generation sequencing in clinical molecular diagnostics of cancer: advantages and challenges","volume":"7","author":"Luthra","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12920-017-0271-4","article-title":"Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing","volume":"10","author":"Cheng","year":"2017","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0012","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/jamaoncol.2015.5208","article-title":"Germline variants in targeted tumor sequencing using matched normal DNA","volume":"2","author":"Schrader","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0013","doi-asserted-by":"crossref","first-page":"283ra53","DOI":"10.1126\/scitranslmed.aaa7161","article-title":"Personalized genomic analyses for cancer mutation discovery and interpretation","volume":"7","author":"Jones","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0014","first-page":"1005","article-title":"Value of paired tumor\u2013normal analysis in solid tumor genotyping by next-generation sequencing","volume":"18","author":"Olar","year":"2016","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0015","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/bjc.2014.518","article-title":"Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours","volume":"111","author":"Singh","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0016","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0017","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1389450114666140106100909","article-title":"Therapeutic targeting of cancers with loss of PTEN function","volume":"15","author":"Dillon","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0018","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S89967","article-title":"PI3K inhibitors as new cancer therapeutics: implications for clinical trial design","volume":"9","author":"Massacesi","year":"2016","journal-title":"OncoTargets Therapy"},{"key":"10.1016\/j.cancergen.2018.04.119_bib0019","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1078-0432.CCR-11-2123","article-title":"PIK3CA\/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors","volume":"18","author":"Meric-Bernstam","year":"2012","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217303964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217303964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:24Z","timestamp":1761896544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217303964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":19,"alternative-id":["S2210776217303964"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.04.119","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in next generation sequencing analysis of somatic mutations in transplant patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.04.119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}